186 related articles for article (PubMed ID: 22562114)
1. The epidemiology and natural history of primary biliary cirrhosis: a nationwide population-based study.
Baldursdottir TR; Bergmann OM; Jonasson JG; Ludviksson BR; Axelsson TA; Björnsson ES
Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):824-30. PubMed ID: 22562114
[TBL] [Abstract][Full Text] [Related]
2. Incidence, prevalence and clinical course of primary biliary cirrhosis in a Spanish community.
Pla X; Vergara M; Gil M; Dalmau B; Cisteró B; Bella RM; Real J
Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):859-64. PubMed ID: 17873609
[TBL] [Abstract][Full Text] [Related]
3. Clinical epidemiology of primary biliary cirrhosis: incidence, prevalence, and impact of therapy.
Lazaridis KN; Talwalkar JA
J Clin Gastroenterol; 2007; 41(5):494-500. PubMed ID: 17450033
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation.
Charatcharoenwitthaya P; Pimentel S; Talwalkar JA; Enders FT; Lindor KD; Krom RA; Wiesner RH
Liver Transpl; 2007 Sep; 13(9):1236-45. PubMed ID: 17763401
[TBL] [Abstract][Full Text] [Related]
5. Four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort.
Jones DE; Bhala N; Burt J; Goldblatt J; Prince M; Newton JL
Gut; 2006 Apr; 55(4):536-41. PubMed ID: 16299032
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of ursodeoxycholic Acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients.
ter Borg PC; Schalm SW; Hansen BE; van Buuren HR;
Am J Gastroenterol; 2006 Sep; 101(9):2044-50. PubMed ID: 16848809
[TBL] [Abstract][Full Text] [Related]
7. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid.
Kuiper EM; Hansen BE; de Vries RA; den Ouden-Muller JW; van Ditzhuijsen TJ; Haagsma EB; Houben MH; Witteman BJ; van Erpecum KJ; van Buuren HR;
Gastroenterology; 2009 Apr; 136(4):1281-7. PubMed ID: 19208346
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: a population-based study.
Myers RP; Shaheen AA; Fong A; Burak KW; Wan A; Swain MG; Hilsden RJ; Sutherland L; Quan H
Hepatology; 2009 Dec; 50(6):1884-92. PubMed ID: 19821525
[TBL] [Abstract][Full Text] [Related]
9. [Primary biliary cirrhosis (PBC)].
Rautiainen H
Duodecim; 2012; 128(15):1550-9. PubMed ID: 22970606
[TBL] [Abstract][Full Text] [Related]
10. Portal hypertension and primary biliary cirrhosis: effect of long-term ursodeoxycholic acid treatment.
Huet PM; Vincent C; Deslaurier J; Coté J; Matsutami S; Boileau R; Huet-van Kerckvoorde J
Gastroenterology; 2008 Nov; 135(5):1552-60. PubMed ID: 18722374
[TBL] [Abstract][Full Text] [Related]
11. [Clinical features and prognosis of primary biliary cirrhosis in Korea].
Kim KA; Jeong SH; Lee JI; Yeon JE; Lee HJ; Kwon SY; Chang UI; Min HJ
Korean J Hepatol; 2010 Jun; 16(2):139-46. PubMed ID: 20606498
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and management of primary biliary cirrhosis.
Ali AH; Carey EJ; Lindor KD
Expert Rev Clin Immunol; 2014 Dec; 10(12):1667-78. PubMed ID: 25382237
[TBL] [Abstract][Full Text] [Related]
13. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation.
Kim WR; Poterucha JJ; Jorgensen RA; Batts KP; Homburger HA; Dickson ER; Krom RA; Wiesner RH; Lindor KD
Hepatology; 1997 Jul; 26(1):22-6. PubMed ID: 9214447
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and incidence of primary biliary cirrhosis are increasing in Finland.
Rautiainen H; Salomaa V; Niemelå S; Karvonen AL; Nurmi H; Isoniemi H; Färkkilä M
Scand J Gastroenterol; 2007 Nov; 42(11):1347-53. PubMed ID: 17918011
[TBL] [Abstract][Full Text] [Related]
15. The natural history of PBC: has it changed?
Lee YM; Kaplan MM
Semin Liver Dis; 2005 Aug; 25(3):321-6. PubMed ID: 16143947
[TBL] [Abstract][Full Text] [Related]
16. Transplantation trends in primary biliary cirrhosis.
Lee J; Belanger A; Doucette JT; Stanca C; Friedman S; Bach N
Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1313-5. PubMed ID: 17900996
[TBL] [Abstract][Full Text] [Related]
17. Primary biliary cirrhosis in Southern Israel: a 20 year follow up study.
Delgado JS; Vodonos A; Delgado B; Jotkowitz A; Rosenthal A; Fich A; Novack V
Eur J Intern Med; 2012 Dec; 23(8):e193-8. PubMed ID: 23022449
[TBL] [Abstract][Full Text] [Related]
18. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
[TBL] [Abstract][Full Text] [Related]
19. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid.
Joshi S; Cauch-Dudek K; Wanless IR; Lindor KD; Jorgensen R; Batts K; Heathcote EJ
Hepatology; 2002 Feb; 35(2):409-13. PubMed ID: 11826416
[TBL] [Abstract][Full Text] [Related]
20. A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre.
Floreani A; Caroli D; Variola A; Rizzotto ER; Antoniazzi S; Chiaramonte M; Cazzagon N; Brombin C; Salmaso L; Baldo V
Liver Int; 2011 Mar; 31(3):361-8. PubMed ID: 21059170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
